| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,737 | 3,205 | 2,338 | 4,042 | | Cost of Revenue | 6,143 | 4,867 | 4,946 | 4,395 | | | Gross Profit | (406) | (1,662) | (2,608) | (353) | | | Operating Expenses | | Research Development | 216 | 198 | 152 | 183 | | Selling General and Administrative | 1,574 | 1,271 | 1,378 | 1,659 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,196) | (3,131) | (4,138) | (2,195) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 136 | 186 | 270 | 312 | | Earnings Before Interest And Taxes | (2,060) | (2,945) | (3,868) | (1,883) | | Interest Expense | 2 |
-
|
-
|
-
| | Income Before Tax | (2,062) | (2,945) | (3,868) | (1,883) | | Income Tax Expense |
-
|
-
|
-
| (169) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,062) | (2,945) | (3,868) | (1,714) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,062) | (2,945) | (3,868) | (1,714) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,062) | ($2,945) | ($3,868) | ($1,714) |
|
1.52% Nasdaq 0.00%
Income Statement
